DEXCOM INC — Director's Dealing 2015

Sep 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-09-09

Reporting Person: LORD JONATHAN T MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-09	Common Stock	S	10000.0	$90.9602	Disposed	131582	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $90.93 to $91.08. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: Included in this number are 4,475 unvested restricted stock units which were granted on June 3, 2015 and shall vest on June 3, 2016.